New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Nuvation Bio Inc. (NUVB) vs Novavax, Inc. (NVAX)
- Nuvation Bio Inc. NUVB 3.81 0.00%
- Novavax, Inc. NVAX 7.74 +0.13%
Nuvation Bio Inc. and Novavax, Inc. are both Biotechnology companies. Nuvation Bio Inc. is the larger, with a market value of $1.4B against $1.3B — 1.1× the size. Nuvation Bio Inc. grew revenue faster over the last twelve months: 654.2% against −61.3%. Novavax, Inc. has the higher net margin (−18.6% vs −67.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Novavax, Inc. leads on 10 and Nuvation Bio Inc. on 5.
Valuation
Profitability
| Metric | NUVB | NVAX | Biotechnology median |
|---|---|---|---|
| Gross margin | 85.79% | 78.01% | 70.18% |
| Operating margin | (61.17%) | (21.23%) | 0.00% |
| Net margin | (67.38%) | (18.64%) | 0.00% |
| Free cash flow margin | (53.62%) | (59.09%) | 0.00% |
| Return on equity | (49.09%) | 41.08% | (51.58%) |
| Return on assets | (19.70%) | (7.42%) | (45.91%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack